-
-
-
-
-
-
-
Raymond James Downgrades Engene Holdings Inc. (ENGN) to Outperform
-
-
-
-
-
-
-
Engene Holdings Inc. (ENGN) PT Lowered to $9 at UBS
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Engene Holdings Inc. (ENGN), Highlights 'Impressive Progress'
-
-
-
-
-
-
-
Engene Holdings Inc. (ENGN) PT Raised to $21 at Leerink Partners
-
-
-
-
-
-
-
Engene (ENGN): FDA Grants RMAT Designation for Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Engene Holdings Inc. (ENGN)
-
-
-
-
-
-
-
Engene (ENGN) Appoints Joan Connolly as CTO, Anthony Cheung as Chief Scientific Officer
-
460,958 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

